SCHEMBL3418683

SCHEMBL3418683

CC(O)(c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1)c1cccc(Cl)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.40
KCNA3 P22001 2/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
OPRK1 P41145 2/20 0.40
KCNH2 Q12809 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP19A1 P11511 2/20 0.40
NR3C1 P04150 2/20 0.40
MEN1 O00255 1/20 0.40
SLC22A1 O15245 1/20 0.40
NR1I2 O75469 1/20 0.40
GMNN O75496 1/20 0.40
USP2 O75604 1/20 0.40
TRPM2 O94759 1/20 0.40
ABCB11 O95342 1/20 0.40
EGFR P00533 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
ERBB2 P04626 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31359426 0.81 CYP2C19 (0.43) KCNN4KCNA3HTR2AHTR2COPRK1
SCHEMBL12510465 0.81 CYP11B1 (0.33) KCNN4KCNA3HTR2AHTR2COPRK1
SCHEMBL3755263 0.81 CYP2C19 (0.43) KCNN4KCNA3HTR2AHTR2COPRK1
SCHEMBL3416281 0.81 TP53 (0.33) KCNN4KCNA3HTR2AHTR2COPRK1
SCHEMBL3742293 0.79 TSHR (0.35) CYP3A4MEN1LMNAMAPTCHRM1
SCHEMBL34464541 0.78 ENPP2 (0.36) CYP11B1CYP11B2SIRT2ENPP2
SCHEMBL13053078 0.77 CYP11B1 (0.42) CYP3A4MEN1TSHRCYP2C19KMT2A
SCHEMBL3746941 0.77 KDM4E (0.33) MEN1MAPTTSHRMAPK1RAB9A
SCHEMBL31284594 0.77 CYP3A4 (0.34) CYP3A4TSHRCYP2C19CYP11B1CYP11B2
SCHEMBL31285619 0.77 CYP3A4 (0.32) KCNA3CYP3A4TSHRCYP2C19CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683089-B1 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists ALLERGAN, INC (US) 2010-03-23 US disclosed
US-7683089-B1 4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists ALLERGAN, INC (US) 2010-03-23 US disclosed
EP-1797043-A1 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS Allergan, Inc. (US) 2007-06-20 EP disclosed
WO-2006036480-A1 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS ALLERGAN, INC. (US) 2006-04-06 WO disclosed